19-19120117-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_017814.3(TMEM161A):c.1253C>T(p.Ala418Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000574 in 1,569,018 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_017814.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM161A | NM_017814.3 | c.1253C>T | p.Ala418Val | missense_variant | 12/12 | ENST00000162044.14 | NP_060284.1 | |
TMEM161A | NM_001411131.1 | c.1178C>T | p.Ala393Val | missense_variant | 12/12 | NP_001398060.1 | ||
TMEM161A | NM_001256766.3 | c.944C>T | p.Ala315Val | missense_variant | 10/10 | NP_001243695.1 | ||
TMEM161A | XM_047439023.1 | c.1202C>T | p.Ala401Val | missense_variant | 12/12 | XP_047294979.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM161A | ENST00000162044.14 | c.1253C>T | p.Ala418Val | missense_variant | 12/12 | 1 | NM_017814.3 | ENSP00000162044.7 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152142Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000565 AC: 8AN: 1416876Hom.: 0 Cov.: 37 AF XY: 0.00000857 AC XY: 6AN XY: 700444
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152142Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74302
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 03, 2024 | The c.1253C>T (p.A418V) alteration is located in exon 12 (coding exon 12) of the TMEM161A gene. This alteration results from a C to T substitution at nucleotide position 1253, causing the alanine (A) at amino acid position 418 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at